Calidi Biotherapeutics prices $4.25M public offering of 5M shares at $0.85/share

Calidi Biotherapeutics, Inc.

Priced public offering of 5,000,000 shares at $0.85 per share for gross proceeds of $4.25 million.
Ladenburg Thalmann acting as exclusive placement agent; fees include 8% cash fee plus 1% management fee.
Placement agent warrants issued to purchase 250,000 shares at $1.0625 per share (125% of offering price).
Lock-up agreements: company 15 days, directors/officers 90 days from closing; agent may waive.
Net proceeds to be used for working capital and general corporate purposes.

item 1.01 item 3.02 item 7.01 item 8.01 item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.